Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.46 | 44.56 |
| PEG Ratio (TTM) | -0.10 | -2.41 |
| P/S Ratio (TTM) | 1.61 | 1.71 |
| P/B Ratio (TTM) | 0.82 | 1.41 |
| P/FCF Ratio (TTM) | -0.88 | 17.75 |
| Price to 5YR AVG Earnings Ratio | N/A | 88.06 |
| Price to 5YR AVG FCF Ratio | N/A | 36.03 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -38.23% | 2.52% |
| ROE (TTM) | -51.28% | 5.68% |
| Net Profit Margin (TTM) | -110.61% | 6.16% |
| ROIC 5YR AVG | N/A | 11.41% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -26.28% | 25.15% | N/A |
| Revenue | 0.57% | 206.16% | N/A |
| Net Income | -26.05% | -28.46% | N/A |
| Cash Flow | 7.76% | -5.11% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.60 | 1.58 |
| Quick Ratio (TTM) | 4.24 | 1.05 |
| D/E Ratio (TTM) | N/A | 0.21 |
| Interest Coverage (TTM) | N/A | 5.76 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 2.33 |
| LTL to 5YR AVG FCF | N/A | 2.83 |
| Shares Outstanding Growth 5YR AVG | N/A | -8.77% |